Clinical use of Prospera in routine transplant care
Prospera Videos
Prospera SurveillanceDr. Ekwenna
Natera ISHLT Symposium
Natera ASTS Symposium
Prospera Validation Studies
The Trifecta Study
- Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies
- Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation
- Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study
Last modified: Thursday, 10 November 2022, 12:08 PM